Publications by authors named "Sara Ferraro"

Claim this Profile
S
Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation.
Giulia Valdiserra, Nadia Mores, Rosalba Elisabetta Rocchi, Laura Sottosanti, Patrizia Felicetti, Sara Ferraro

Front Drug Saf Regul· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation remodeling in temozolomide resistant recurrent glioblastoma: comparing epigenetic dynamics in vitro and in vivo.
Michela Buonaiuto, Mariella Cuomo, Davide Costabile, Federica Trio, Sara Ferraro

J Transl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database.
Sara Ferraro, Emiliano Cappello, Marco Fornili, Irma Convertino, Marco Bonaso

Drug Saf· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option.
Sara Ferraro, Irma Convertino, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso

Expert Opin Drug Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use.
Sara Ferraro, Emiliano Cappello, Claudia Bartolini, Irma Convertino, Lorenzo Bertani

Eur J Gastroenterol Hepatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Irma Convertino, Massimiliano Cazzato, Silvia Tillati, Sabrina Giometto, Rosa Gini, Sara Ferraro

Front Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.
Liliana Montella, Mariella Cuomo, Nunzio Del Gaudio, Michela Buonaiuto, Davide Costabile, Sara Ferraro

Int J Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cases of acquired hemophilia A following COVID-19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy.
Giuseppe Roberto, Olga Paoletti, Sara Ferraro, Giulia Hyeraci, Massimo Franchini

Pharmacoepidemiol Drug Saf· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence.
Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso

Expert Opin Drug Discov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sara Ferraro

Pharmaceuticals (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylome Profiling in Fabry Disease in Clinical Practice: A Proof of Concept.
Teodolinda Di Risi, Mariella Cuomo, Roberta Vinciguerra, Sara Ferraro, Rosa Della Monica

Int J Mol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall.
Marco Tuccori, Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra

Expert Opin Drug Discov· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: Preclinical and clinical data.
Federico Cucchiara, Sara Ferraro, Giacomo Luci, Guido Bocci

Pharmacol Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future.
Marco Tuccori, Irma Convertino, Sara Ferraro, Giulia Valdiserra, Emiliano Cappello

Expert Opin Drug Discov· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GDM-complicated pregnancies: focus on adipokines.
Marta Mallardo, Sara Ferraro, Aurora Daniele, Ersilia Nigro

Mol Biol Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study.
Irma Convertino, Sabrina Giometto, Rosa Gini, Massimiliano Cazzato, Marco Fornili, Sara Ferraro

J Clin Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases.
Irma Convertino, Massimiliano Cazzato, Sabrina Giometto, Rosa Gini, Giulia Valdiserra, Sara Ferraro

Sci Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons.
Irma Convertino, Ersilia Lucenteforte, Rosa Gini, Valentina Lorenzoni, Massimiliano Cazzato, Sara Ferraro

Clin Exp Rheumatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs.
Sara Ferraro, Marco Tuccori, Irma Convertino, Giulia Valdiserra, Emiliano Cappello

Br J Clin Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.
Marco Tuccori, Sara Ferraro, Irma Convertino, Emiliano Cappello, Giulia Valdiserra

MAbs· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.
Marco Tuccori, Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra

Drug Saf· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse primary cutaneous infection by in a liver transplant recipient with pulmonary nocardiosis: Importance of prompt identification for clinical resolution.
Caterina Campoli, Sara Ferraro, Nunzio Salfi, Simona Coladonato, Maria Cristina Morelli

Med Mycol Case Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients.
Irma Convertino, Marco Tuccori, Sara Ferraro, Giulia Valdiserra, Emiliano Cappello

Crit Care· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unresolved gustatory, olfactory and auditory adverse drug reactions to antibiotic drugs: a survey of spontaneous reporting to Eudravigilance.
Sara Ferraro, Irma Convertino, Luca Leonardi, Corrado Blandizzi, Marco Tuccori

Expert Opin Drug Saf· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis